Figure 1.
Figure 1. Reovirus effect on stem cells. (A) Lack of reovirus effect on cultured stem cells. CD34+ cells were isolated using negative selection columns and cultured in StemSpan medium in the presence or absence of reovirus (40 MOI). Cells were harvested 0, 1, 2, and 5 days after virus infection, and CD34+ cells were enumerated by flow cytometry. Error bars indicate the standard deviation of the mean of 3 replicates. (B) Lack of reovirus effect on stem cell progenitor assay. Stem cells (CD34+) were selected and treated with reovirus as described. Samples taken at the days indicated were cultured in methylcellulose and scored for CFU-GMs, BFU-Es, and CFU-GEMMs. NV indicates no virus; LV, live virus. Error bars indicate the standard deviation of the mean of 3 replicate plates. (C) Lack of reovirus protein synthesis detected by [35S]-methionine labeling in apheresis product primed with G-CSF. Apheresis product cells were primed with G-CSF and pulse labeled with [35S]-methionine with or without reovirus treatment (40 MOI). At time points indicated in the figure, cellular proteins were harvested and subjected to SDS-PAGE. Reovirus marker proteins (λ, μ, and σ) are indicated in lane 1. Note the absence of viral protein bands at all time points after virus infection.

Reovirus effect on stem cells. (A) Lack of reovirus effect on cultured stem cells. CD34+ cells were isolated using negative selection columns and cultured in StemSpan medium in the presence or absence of reovirus (40 MOI). Cells were harvested 0, 1, 2, and 5 days after virus infection, and CD34+ cells were enumerated by flow cytometry. Error bars indicate the standard deviation of the mean of 3 replicates. (B) Lack of reovirus effect on stem cell progenitor assay. Stem cells (CD34+) were selected and treated with reovirus as described. Samples taken at the days indicated were cultured in methylcellulose and scored for CFU-GMs, BFU-Es, and CFU-GEMMs. NV indicates no virus; LV, live virus. Error bars indicate the standard deviation of the mean of 3 replicate plates. (C) Lack of reovirus protein synthesis detected by [35S]-methionine labeling in apheresis product primed with G-CSF. Apheresis product cells were primed with G-CSF and pulse labeled with [35S]-methionine with or without reovirus treatment (40 MOI). At time points indicated in the figure, cellular proteins were harvested and subjected to SDS-PAGE. Reovirus marker proteins (λ, μ, and σ) are indicated in lane 1. Note the absence of viral protein bands at all time points after virus infection.

Close Modal

or Create an Account

Close Modal
Close Modal